PHARMACY AND MANUFACTURING PARTNERSHIPS

Arch Healthcare, Inc is committed to ensuring that all compounded and sterile pharmaceutical products accessed through the Umiwell Platform meet the highest standards of safety, precision, and regulatory compliance. To achieve this, we partner exclusively with compounding pharmacies that have obtained accreditation from the Pharmacy Compounding Accreditation Board (PCAB). PCAB accreditation is granted only to pharmacies that demonstrate adherence to rigorous operational standards, including the consistent formulation, preparation, and dispensing of medications pursuant to individualized prescription orders. These standards are specifically designed to ensure that compounded products meet quality benchmarks for identity, potency, purity, and uniformity. Through this collaboration, we are able to assure patients that the medications they receive have been produced in strict accordance with best practices in pharmaceutical compounding and are tailored to their personal therapeutic needs.
In addition to our PCAB-accredited pharmacy partners, Arch Healthcare, Inc also engages with FDA-registered outsourcing facilities operating under Section 503B of the Federal Food, Drug, and Cosmetic Act for the preparation of sterile drug products. These outsourcing facilities are subject to direct regulatory oversight by the U.S. Food and Drug Administration (FDA), including compliance with current Good Manufacturing Practices (cGMP) for sterile production. By partnering with qualified 503B manufacturers, we ensure that sterile medications supplied through the Umiwell Platform are produced under stringent quality control protocols, thereby supporting patient safety and therapeutic efficacy. Our selection of accredited partners reflects our ongoing commitment to transparency, clinical integrity, and the reliable delivery of pharmaceutical care.